"Vestibulitis Educational Seminar Trial" Study

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT00278850
Collaborator
(none)
500
1
37.9
13.2

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the efficacy of an educational seminar series for women with vulvar vestibulitis syndrome (VVS).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Educational

Detailed Description

HYPOTHESIS: It is hypothesized that this educational seminar series might be effective in reducing the pain experienced and improving sexual response and quality of life of women with Vulvar Vestibulitis Syndrome (VVS) by providing an open forum for discussion of the pathology, etiological theories, treatment plans as well as the impact of sexual pain on sexual relationships and ways to cope with VVS.

At Vancouver Hospital, the current waitlist for women with distressing, unremitting genital pain is approximately 10 months. Once accepted for management, the diagnosis of VVS is given, where applicable, by Dr. Sadownik. Only women with pure VVS and without a compounding skin condition are then referred on to the 3-session educational seminars given by Dr. Thomson. By the end of the educational series, women have an understanding of current scientific literature on etiology and treatment of VVS, and it's interaction with sexual health factors. At this point they are referred for individualized treatment of the VVS either by Dr. Thomson, Dr. Sadownik or back to their referring physician. This study aims to explore the existing VVS Educational Seminars by measuring sexual function, sexual distress, pain levels (general pain, genital pain and pain upon sexual activity), psychological well-being (depression and anxiety), relationship satisfaction, sexual knowledge and overall quality of life at pre- and post seminar. An age-matched control group of women diagnosed with VVS, but unable to attend the Seminar series, will complete the measures at the same intervals as the treatment group. The use of the control group allows us to accurately evaluate the efficacy of the Educational seminars, above and beyond non-specific factors.

Vulvar Vestibulitis Syndrome Educational Seminars have been run through the Vulvar Disease Clinic at Vancouver Hospital since 2001, however no data has been collected to determine the effects of this program. By collecting pre- & post seminar and follow up data, this study will allow us to assess the efficacy of the VVS Educational Seminars when compared to a group of women suffering from VVS but unable to attend the information seminars. Given that a large proportion of the women cannot be treated at Vancouver Hospital and are instead referred back to their family physician, the VVS Educational Seminar is a necessary first step in the treatment process for ensuring that women receive accurate and timely treatment. It will also help treatment providers improve and expand their current treatment practices

Study Design

Study Type:
Observational
Actual Enrollment :
500 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
"Vestibulitis Educational Seminar Trial" Study
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Mar 1, 2009
Actual Study Completion Date :
Mar 1, 2009

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women who meet the diagnostic criteria for VVS by the Vancouver Hospital Vulvar Disease Clinic

    • Women who have been referred to VVS Educational Seminars at Vancouver Hospital

    • Proficient in English

    Exclusion Criteria:
    • Any women referred to the VVS Educational Seminars will be eligible for participation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vancouver Hospital Vancouver British Columbia Canada V5Z 1M9

    Sponsors and Collaborators

    • University of British Columbia

    Investigators

    • Principal Investigator: Lori A Brotto, PhD, University of British Columbia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Lori Brotto, Associate Professor, University of British Columbia
    ClinicalTrials.gov Identifier:
    NCT00278850
    Other Study ID Numbers:
    • C05-0592
    First Posted:
    Jan 18, 2006
    Last Update Posted:
    Jun 15, 2015
    Last Verified:
    Jun 1, 2015
    Keywords provided by Lori Brotto, Associate Professor, University of British Columbia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 15, 2015